Mergers & Acquisitions - Legal, Mergers & Acquisitions

Filter

Popular Filters

UK M&A regulator consults on more stringent regulations

UK M&A regulator consults on more stringent regulations

16-09-2014

Partly in response to the recent (failed, thus far) attempt by US pharma giant Pfizer to acquire Anglo-Swedish…

LegalMergers & AcquisitionsPfizerPharmaceuticalUK

Allergan moves to block Valeant and Pershing Square from voting shares acquired in violation of insider trading laws

27-08-2014

Hostile takeover target Allergan has asked the US District Court for the Central District of California…

AllerganLegalMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

Allergan sues Valeant and Pershing Square, alleging insider trading

Allergan sues Valeant and Pershing Square, alleging insider trading

02-08-2014

US Botox maker Allergan, the subject of a hostile $53 billion takeover attempt by Canada’s Valeant…

AllerganBusiness FinanceLegalMergers & AcquisitionsPharmaceuticalUSAValeant Pharmaceuticals International

UK Business Secretary to set out new takeover rules

UK Business Secretary to set out new takeover rules

13-07-2014

UK Business Secretary Vince Cable is shortly to announce new regulations to deal with foreign takeover…

LegalMergers & AcquisitionsPfizerPharmaceuticalUKVince Cable

European Commission approves JV between Fresenius and Sistema

European Commission approves JV between Fresenius and Sistema

19-06-2014

The European Commission has cleared under the EU Merger Regulation the creation of a joint venture between…

AFK SistemaFreseniusLegalMergers & AcquisitionsPharmaceuticalRussia

Pershing Square files law suit over Allergan’s rights plan

Pershing Square files law suit over Allergan’s rights plan

15-06-2014

William Ackman's Pershing Square Capital Management has filed a law suit in the Delaware Court of Chancery…

AllerganLegalMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

Indian court ruling lifts temporary stay on Sun Pharma takeover of Ranbaxy

26-05-2014

Indian generics drugmaker Sun Pharmaceuticals’ proposed $3.2 billion acquisition of loss-making rival…

Daiichi SankyoGenericsLegalMergers & AcquisitionsRanbaxy LaboratoriesSun Pharmaceuticals

Genesis 2013: Secrets of B-MS and AstraZeneca Amylin deal revealed

Genesis 2013: Secrets of B-MS and AstraZeneca Amylin deal revealed

16-12-2013

Secrets of how Bristol-Myers Squibb and AstraZeneca arranged a behind-the-scenes deal to buy Amylin were…

AmylinAstraZenecaBristol-Myers SquibbDiabetesInterviewsLegalMergers & AcquisitionsPharmaceuticalUKUSA

FTC highlights focus on health care markets competition before Judiciary subcommittee

17-11-2013

The USA’s Federal Trade Commission described its ongoing efforts to protect competition and consumers…

HealthcareLegalMergers & AcquisitionsNorth AmericaPharmaceutical

US FTC finalizes amendments to the premerger notification rules on patent right transfers

07-11-2013

The US Federal Trade Commission yesterday (November 6) issued final changes to the premerger notification…

LegalMergers & AcquisitionsNorth AmericaPatentsPharmaceutical

Actavis and Warner Chilcott to sell products to settle charges by FTC that their merger is 'uncompetitive'

Actavis and Warner Chilcott to sell products to settle charges by FTC that their merger is 'uncompetitive'

28-09-2013

Actavis has agreed to sell all rights and assets to four generic pharmaceuticals to settle US Federal…

ActavisAmneal PharmaAtelviaFemcon FeGenericsLegalLoestrin 24 FeMergers & AcquisitionsWarner ChilcottWomen's Health

Generics briefs: Actavis/Warner Chilcott M&A delay; Canasa patent challenge

11-07-2013

US generics major Actavis (NYSE: ACT) and Ireland-based Warner Chilcott (Nasdaq: WCRX) have each received…

ActavisAptalis PharmaCanasaGenericsLegalMergers & AcquisitionsMylan LaboratoriesNorth AmericaPatentsWarner Chilcott

Elan details further inadequacy of Royalty Pharma's revised offer; takes legal action

04-06-2013

The saga of Royalty Pharma's hostile attempts to acquire Ireland-headquartered Elan Corp (NYSE: ELN)…

ElanLegalMergers & AcquisitionsPharmaceuticalRoyalty Pharma

Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal

12-02-2013

The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating…

Asia-PacificCiplaCipla MedproGenericsLegalMergers & AcquisitionsOncologyPatentsPfizerRest of the WorldSutent

News briefs from Sanofi, Bayer, GlaxoSmithKline and Novartis

21-12-2012

French drug major Sanofi (Euronext: SAN) has entered into a binding agreement to acquire the animal health…

BayerDosch PharmaceuticalsExjadeFlonaseGlaxoSmithKlineLegalMergers & AcquisitionsMerialNovartisOncologyPharmaceuticalregorafenibRegulationRespiratory and PulmonarySanofi

US FTC puts divestment conditions on Watson's acquisition of Actavis

16-10-2012

The USA's Federal Trade Commission will require Watson Pharmaceuticals (NYSE: WPI) and fellow generic…

ActavisGenericsLegalMergers & AcquisitionsNorth AmericaNovartisPar PharmaceuticalsSandozWatson Pharmaceuticals

Flaws in ESI/Medco efficiency claims exposed

20-02-2012

David Balto, an antitrust attorney in Washington DC, USA, and former Policy Director of the Federal Trade…

Express ScriptsLegalMedcoMergers & AcquisitionsPharmaceutical

US antitrust body OKs Teva's acquisition of Cephalon, but with divestments

10-10-2011

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) says that the US Federal Trade Commission…

CephalonGenericsLegalMergers & AcquisitionsNorth AmericaPar PharmaceuticalsPharmaceuticalProvigilTeva Pharmaceutical Industries

Back to top